Filing Details

Accession Number:
0001209191-18-011018
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-16 18:25:19
Reporting Period:
2018-02-16
Accepted Time:
2018-02-16 18:25:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591213 A Paul Foster C/O Xencor, Inc.
111 West Lemon Avenue
Monrovia CA 91016
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-16 5,000 $0.59 7,419 No 4 M Direct
Common Stock Disposition 2018-02-16 5,000 $25.01 2,419 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-02-16 5,000 $0.00 5,000 $0.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
48,064 2022-09-25 No 4 M Direct
Footnotes
  1. Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.
  2. The stock option is fully vested.